logo
US Fed independence under threat, say economists, but no one expects a July rate cut- Reuters poll

US Fed independence under threat, say economists, but no one expects a July rate cut- Reuters poll

Reuters23-07-2025
BENGALURU, July 23 - The U.S. Federal Reserve's independence is under threat from mounting political interference, according to a clear majority of economists polled by Reuters, although no one expects a July interest rate cut despite a recent divergence in views among policymakers.
President Donald Trump has made it almost a daily routine to personally attack Fed Chair Jerome Powell over the central bank's stance of holding rates due to tariff-related risks of higher inflation. A recent jump in inflation suggests businesses are now passing some of the tariffs onto consumers.
Most Federal Market Open Committee members favor holding rates steady, but a few, including Governor Chris Waller and Trump appointee Fed Vice Chair for Supervision Michelle Bowman, have recently advocated a reduction as soon as July 30.
Powell's term is set to expire in May 2026. Waller last week said he would accept the job as the bank's head if he was offered it by Trump.
An over 70% majority of economists in the July 17-23 Reuters poll who answered an additional question, 36 of 50, said they were worried about the Fed's independence from political influence, including 10 who said they were very concerned. The remaining 14 said they were not.
"I am more worried about the Fed's independence than I was a few months ago, and the main reason for that is the recent behaviour of Governors Bowman and Waller. It's very notable they are diverging from the consensus," said Philip Marey, senior U.S. strategist at Rabobank.
"This year is still Powell's Fed. The current Fed is very cautious and wants to wait for the data and go only when they're sure ... It is kind of a policy paralysis at the moment and I don't think that will change as long as Powell has some grip on the FOMC," he added.
All 105 economists said the Fed, which last cut its key interest rate to 4.25%-4.50% in December, will hold rates again at the conclusion of its July 29-30 meeting. Most respondents maintained their rate outlook or expected fewer reductions compared with a poll taken last month.
A slight 53% majority of economists, 56 of 105, forecast a cut in September, in line with market pricing.
But with less than half the year remaining, a clear consensus on where rates would be by end-2025 remains elusive. Economists are waiting for clarity on trade policies as a deadline for Trump's so-called "reciprocal" tariffs first announced in April approaches. That deadline of August 1 is itself an extension from a previous July 9 deadline.
"Tariffs could affect things both in terms of higher inflation (and) it could slow the economy. The Fed doesn't know exactly what that mix is going to be and that's reason enough to wait," said Jonathan Millar, senior U.S. economist at Barclays.
Just under two-thirds of forecasters expect one or two rate cuts this year, with nearly a fifth expecting no cuts at all. Interest rate futures are pricing in two reductions. The Fed will cut twice next year, poll medians showed.
"We've had a very substantial easing of policy over the last few months just from the fact the dollar has weakened and improvements in equity markets. It's not as if things are really screaming out for a rate cut," Millar said.
Inflation forecasts were broadly unchanged from last month, with economists forecasting it will average above the Fed's 2% target through at least 2027.
The recent passage of Trump's signature spending bill, expected to add $3.4 trillion to an already enormous $36.2 trillion debt pile, poses a further risk of reigniting price pressures.
The economy, which contracted 0.5% last quarter, is forecast to grow just 1.5% this year, a sharp slowdown from 2.8% in 2024.
Next year, it was expected to expand 1.6%, a view that has remained steady since May.
(Other stories from the Reuters global economic poll)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Regeneron beats second-quarter results estimates on Dupixent sales boost
Regeneron beats second-quarter results estimates on Dupixent sales boost

Reuters

time21 minutes ago

  • Reuters

Regeneron beats second-quarter results estimates on Dupixent sales boost

Aug 1 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab beat Wall Street estimates for second-quarter revenue and profit on Friday helped by robust demand for its blockbuster eczema treatment, Dupixent, sending its shares up nearly 3% in premarket trading. Investors have set a high bar for Regeneron and French partner Sanofi's ( opens new tab Dupixent, one of the U.S. drugmaker's growth drivers, especially after it received approval to treat a common lung condition called chronic obstructive pulmonary disease last year. Sales of the anti-inflammatory drug rose 22% to $4.34 billion, compared with an estimate of $4.14 billion. The Tarrytown, New York-based company is also banking its cancer treatment, Libtayo, to drive future growth at a time when its blockbuster eye disease drug Eylea has been grappling with stiff competition from cheaper versions and rival drugs such as Roche's (ROG.S), opens new tab Vabysmo. U.S. sales of Eylea, jointly developed with Bayer AG ( opens new tab, fell 25% to $1.15 billion, including $393 million from the higher, 8-milligram dose version of the drug. Analysts were expecting $2.17 billion in total Eylea sales. Roche reported Vabysmo sales of 2.07 billion Swiss francs ($2.54 billion) last week, slightly below analyst expectations. On an adjusted basis, Regeneron earned a quarterly profit of $12.89 per share, compared with analysts' average expectation of $8.44 per share, according to data compiled by LSEG. The company's total revenue for the quarter was $3.68 billion, above an expectation of $3.28 billion. Skin cancer drug Libtayo brought in sales of $377 million, versus analysts' average estimate of $338.75 million. Separately, Regeneron is among 17 drugmakers that have received a letter from the U.S. President Donald Trump asking them to slash U.S. prescription drug prices to match overseas rates. ($1 = 0.8161 Swiss francs)

Ukrainians mourn 31 killed in Russian strike on Kyiv
Ukrainians mourn 31 killed in Russian strike on Kyiv

Reuters

time21 minutes ago

  • Reuters

Ukrainians mourn 31 killed in Russian strike on Kyiv

KYIV, Aug 1 (Reuters) - Ukrainian rescuers recovered more than a dozen more bodies from the rubble of a collapsed apartment block in Kyiv overnight, bringing the death toll from Russia's worst air strike of the year on Ukraine's capital to 31. A two-year-old was among the five children found dead after Thursday's sweeping Russian drone and missile attack, President Volodymyr Zelenskiy said on Friday, announcing the end of a more than 24-hour-long rescue operation. A total of 159 people were wounded in the multi-wave strike, in which Russia launched more than 300 drones and eight missiles early on Thursday, the latest in a campaign of fierce strikes on Ukrainian towns and cities. The worst damage was to an apartment building that partially collapsed in the Sviatoshyn district in western Kyiv. Damage was also reported in at least three other districts of the capital. U.S. President Donald Trump on Thursday sharply criticised Russia's "disgusting" behaviour against Ukraine, while saying he was not sure whether sanctions would deter Russia. He has given President Vladimir Putin until August 8 to make a deal or else he will respond with economic pressure. Natalia Matviyenko, 65, sitting near the damaged apartment building, said she did not place much faith in Trump's tough rhetoric. "Trump just says, 'I'm upset with President Putin's behaviour.' And what? No results," she said. The U.S. leader, who returned to power on a pledge to swiftly end the war, has in recent weeks rolled back his earlier conciliatory approach toward Moscow and signalled openness to arming Ukraine. But a diplomatic effort to end the war has stalled, with Moscow not backing down from what Kyiv and its allies describe as maximalist demands. On Friday, mourners laid flowers and lit candles at the wrecked apartment block, where rumbling excavators hoisted heavy pieces of rubble. The makeshift shrine included brightly coloured stuffed animals. Oksana Kinal, 43, who was placing flowers to honour a co-worker who had been killed alongside a son, said she hoped Trump would follow up on his threat but also expressed doubt. "I think America has a lot of points of leverage that can be used against Russia," she said. "But will Putin listen to this? I don't know." Kyiv's air force said on Friday that Ukrainian air defences had destroyed more than 6,000 drones and missiles across the country in July alone. "The world possesses every instrument required to ensure Russia is brought to justice," Prime Minister Yulia Svyrydenko wrote on X on Friday. "What is lacking is not power — but will."

Record viewing figures for South Park new season debut
Record viewing figures for South Park new season debut

The Independent

time23 minutes ago

  • The Independent

Record viewing figures for South Park new season debut

The premiere of South Park season 27, which heavily satirised Donald Trump, achieved record-breaking viewership figures. The episode, titled "Sermon on the Mount," attracted 5.9 million viewers across Comedy Central and Paramount+, marking its best season premiere rating since 2022. Paramount reported that it was also the show's biggest share of a cable audience for a season premiere since 1999 and its "most social episode" to date. A spokesperson for Donald Trump criticised the episode, dismissing it as "uninspired" and claiming the show lacked relevance. South Park creators Trey Parker and Matt Stone issued a sarcastic apology, with future episodes also set to feature satirical portrayals of Trump.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store